Testing this hypothesis regarding the involvement of N-MYC (SPT16) in the pathogenesis of AML, resulting in cohesin accumulation and impaired DNA replication, requires additional experiments using cell lines derived from FLT3-ITD-positive AML patients. The gene discussed is MYCN; the disease is acute myeloid leukemia.